Mallinckrodt (J&J) is one of five drugmakers attempting to settle litigation relating to the opioid crisis by participating in Purdue Pharma's bankruptcy proceedings, according to a Wall Street Journal report. The companies are reportedly exploring a way to close the cases by enacting a global settlement, which would release the firms from liability in exchange for contributing money into a trust set up through the bankruptcy. Johnson & Johnson, one of the other firms reported as being involved, said suggestions it wants to leverage the bankruptcy are “completely unfounded”.
Johnson & Johnson (J&J) is one of five drugmakers attempting to settle litigation relating to the opioid crisis by participating in Purdue Pharma's bankruptcy proceedings, according to a Wall Street Journal report. The companies are reportedly exploring a way to close the cases by enacting a global settlement, which would release the firms from liability in exchange for contributing money into a trust set up through the bankruptcy. Mallinckrodt, one of the other firms reported as being involved, said suggestions it wants to leverage the bankruptcy are “completely unfounded”.